ARTICLE | Clinical News
Accelr8 Technology preclinical data
November 10, 2008 8:00 AM UTC
In 126 bacterial strains, Accelr8's ESBL test had 96% sensitivity and 96% specificity in detecting extended-spectrum beta lactamase (ESBL)-resistant bugs. The test produced results in 90-180 minutes....